据悉，"大国食匠"荣誉旨在表彰为中国食品工业高质量发展作出杰出贡献的领军人物，是行业对个 人专业能力与责任担当的高度认可。蔡金垵此次获奖，不仅彰显了其个人在行业发展中的卓越领导力与 前瞻性视野，更标志着盼盼食品集团作为中国休闲食品行业领军企业，在新时代背景下持续引领行业转 型升级的典范地位获得权威肯定。作为行业标杆企业，盼盼食品集团近年来坚定锚定"大健康"发展方 向，不断优化产品结构，加大科技研发与绿色制造投入，积极布局功能性食品、健康饮品等新兴领域， 成功实现从传统休闲食品向营养健康食品的全面转型，为行业发展提供了可借鉴的实践经验。 中国质量新闻网讯 近日，第111届全国糖酒商品交易会（秋糖会）期间，恰逢全国糖酒商品交易会 创办70周年，中国食品工业协会与全国糖酒商品交易会组委会联合举办重磅表彰活动，正式发布推动我 国食品工业发展的70位标杆人物及70个典范品牌。其中，盼盼食品集团董事长蔡金垵凭借在行业内的突 出贡献，被授予"大国食匠"荣誉称号，成为食品工业高质量发展进程中的重要标杆。 面向未来，盼盼食品集团将继续以"健康中国"战略为核心指引，持续深化大健康产业布局，在产品 创新、技术升级、绿色发展等方面持 ...

Group 1 - The core point of the article is that Yili Holdings (00076) has transferred shares worth HKD 3.3672 million, representing 5.49% of its stock, from Greater Bay Area Shen Kong Securities to DBS Bank Hong Kong on December 23 [1] - Yili Holdings announced a three-year cooperation management contract with Qingdao Tiantai Cultural Tourism Industry Group, effective from December 23, 2025 [1] - The contract involves collaboration to expand Qingdao's golf courses and natural hot spring hotels, integrating artificial intelligence and health concepts into the business [1] Group 2 - Qingdao Tiantai will pay Yili Holdings a management fee of RMB 1 million, with 10% due within 30 days of signing and the remaining 90% by December 31, 2026 [1] - If Qingdao Tiantai achieves a profit of RMB 50 million by 2026, Yili Holdings will receive an additional 10% share of the profits, to be paid by January 31, 2027 [1] - As of November 30, 2025, Qingdao Tiantai reported a revenue of RMB 65 million and a profit of RMB 25 million for the 11 months [1]

Group 1 - The core point of the article is that Yili Holdings (00076) has transferred shares worth HKD 3.3672 million from Greater Bay Area Shen Kong Securities to DBS Bank Hong Kong, representing 5.49% of the total shares [1] - Yili Holdings announced a three-year cooperation management contract with Qingdao Tiantai Cultural Tourism Industry Group, effective from December 23, 2025 [1] - The contract involves collaboration to expand Qingdao's golf courses and natural hot spring hotels, incorporating artificial intelligence and health concepts into the business [1] Group 2 - Qingdao Tiantai will pay Yili Holdings a management fee of RMB 1 million, with 10% due within 30 days of signing and the remaining 90% by December 31, 2026 [1] - If Qingdao Tiantai achieves a profit of RMB 50 million by 2026, Yili Holdings will receive an additional 10% share of the profits, to be paid by January 31, 2027 [1] - As of November 30, 2025, Qingdao Tiantai reported a revenue of RMB 65 million and a profit of RMB 25 million for the preceding 11 months [1]

Core Viewpoint - Northeast Pharmaceutical is focusing on market trends, leveraging its two core sales segments, raw materials and formulations, to achieve significant results and ensure stable performance for the company [1] Raw Material Segment - Northeast Pharmaceutical is a key global supplier of raw materials, enhancing its international market competitiveness, particularly in the EU and Japan/Korea, with market share increasing year by year [2] - The raw material sales company demonstrated strong market capabilities in Q4, with profits exceeding planned targets for two consecutive months in October and November, particularly in November [2] - Key products such as Vitamin C and L-Carnitine exceeded sales targets, while other products like Amantadine and Piracetam also performed well, enhancing the product matrix's competitiveness [2] - The company actively participated in major industry exhibitions to connect with core customer needs and adjust market strategies based on competitor insights [2][3] Formulation Segment - Northeast Pharmaceutical's formulation products rank first in domestic sales, contributing to economic benefits and enhancing brand recognition [4] - The formulation sales company is focusing on maintaining and expanding the market competitiveness of key products, with systematic planning for products like Gut Health and Pain Relief tablets [4] - Efficient execution and collaboration among teams have led to achieving monthly performance targets, providing confidence for year-end goals [4][5] Expansion into New Fields - In Q4, Northeast Pharmaceutical made significant strides in the health sector by launching new products such as health biscuits and advancing the development of additional health-oriented snacks [6] - The company is exploring the beauty sector with functional skincare products, leveraging its pharmaceutical-grade standards in product development [6] - The company aims to optimize its health product matrix and explore comprehensive health services, creating new growth points [6]

Core Insights - The company is focusing on market trends, with its two core sales segments, raw materials and formulations, playing a significant role in stabilizing performance and achieving important results in market penetration [1][2] - The company is actively expanding in the health sector, launching new products that contribute to comprehensive health services, providing confidence and direction for future work [1][4] Raw Material Segment - The company is a key global supplier of raw materials, enhancing its international market competitiveness, particularly in the EU and Japan, with market share increasing year by year [1][2] - In Q4, the raw material sales company demonstrated strong market capabilities, exceeding profit targets in October and November, with notable performance in November [1][2] - Key products such as Vitamin C and L-Carnitine significantly outperformed sales targets, indicating a strengthening product matrix [1][2] Market Expansion and Management - The raw material sales company has actively participated in major industry exhibitions to engage with core customers and align market orders, while also monitoring industry trends and competitor dynamics [2] - Internal management has been enhanced, with a focus on accountability and improving business capabilities, leading to effective collaboration across departments [2] Formulation Segment - The company has several formulation products that rank first in domestic sales, contributing to economic benefits and enhancing brand recognition [3] - A systematic approach has been adopted to boost sales of key products, with effective execution leading to monthly performance improvements [3] New Product Development - In Q4, the company made significant strides in the health sector by launching new products such as health-oriented biscuits, while also developing additional products to meet diverse health needs [4] - The company is leveraging its experience in R&D and quality control to explore the health food sector, including functional skincare products that integrate pharmaceutical technology [4][5] Strategic Focus - The company aims to leverage its comprehensive advantages in innovation, resource allocation, and market positioning to optimize its health product matrix and explore new growth points in the health sector [5]

Core Viewpoint - Yili Holdings (00076) has announced a three-year cooperation management agreement with Qingdao Tiantai Cultural Tourism Industry Group, focusing on expanding business in golf courses and natural hot spring hotels, integrating AI technology and health concepts into operations [1] Group 1: Agreement Details - The agreement will commence on January 1, 2026, with Yili's subsidiary collaborating with Qingdao Company [1] - Qingdao Company will pay a management fee of 1 million RMB, with 10% due within 30 days of signing and the remaining 90% to be paid by December 31, 2026 [1] - If Qingdao Company achieves a profit of 50 million RMB in 2026, Yili's subsidiary will receive an additional 10% share of the profits, payable by January 31, 2027 [1] Group 2: Financial Performance - As of November 30, 2025, Qingdao Company reported a revenue of 65 million RMB and a profit of 25 million RMB for the 11 months [1]

Core Viewpoint - The announcement highlights a three-year cooperation management agreement between the company's wholly-owned subsidiary and Qingdao Tiantai Cultural Tourism Industry Group, focusing on business expansion in golf courses and natural hot spring hotels, integrating AI technology and health concepts into operations [1] Group 1: Agreement Details - The cooperation management agreement will commence on January 1, 2026, and involves collaboration in expanding the business of golf courses and natural hot spring hotels under Qingdao Company [1] - Qingdao Company will pay a management fee of 1 million RMB to the subsidiary, with 10% due within 30 days of signing and the remaining 90% to be paid by December 31, 2026 [1] - If Qingdao Company achieves a profit of 50 million RMB in 2026, the subsidiary will receive an additional 10% share of the profits, to be paid by January 31, 2027 [1] Group 2: Financial Performance - As of November 30, 2025, Qingdao Company reported a revenue of 65 million RMB and a profit of 25 million RMB for the 11 months [1]

Core Viewpoint - Yili Holdings (00076) has announced a three-year cooperation management agreement with Qingdao Tiantai Cultural Tourism Industry Group, focusing on expanding business in golf courses and natural hot spring hotels, integrating AI technology and health concepts into operations [1] Group 1: Agreement Details - The agreement will commence on January 1, 2026, with Yili's subsidiary collaborating with Qingdao Company [1] - Qingdao Company will pay a management fee of 1 million RMB, with 10% due within 30 days of signing and the remaining 90% to be paid by December 31, 2026 [1] - If Qingdao Company achieves a profit of 50 million RMB in 2026, Yili's subsidiary will receive an additional 10% share of the profits, payable by January 31, 2027 [1] Group 2: Financial Performance - As of November 30, 2025, Qingdao Company reported a revenue of 65 million RMB and a profit of 25 million RMB for the 11 months [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負 責，對其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部 或任何部份內容而產生或因倚賴該等內容而引致之任何損失承擔任何責任。 ELATE HOLDINGS LIMITED 誼礫控股有限公司 （ 於香港註冊成立之有限公司） （ 股份代號： 076） 自願公告 業務發展最新情況 本公司董事會(「董事會」)欣然宣布，本公司之全資附屬公司誼礫石墨有限公司 （「子公司」）和青島天泰文旅產業集團有限公司（「青島公司」）於二零二五年 十二月二十三日簽訂為期三年之合作管理合約（「該合約」）。合約主要內容為： 1 1. 從二零二六年一月一日起，子公司將與青島公司合作拓展青島公司屬下的高 爾夫球場和天然溫泉酒店等業務。子公司將引進人工智能技術及以大健康概 念融入青島公司業務中。 2. 訂約雙方同意青島公司將向子公司支付 100 萬元人民幣合作管理費，簽約後 30 天內支付 10%，另外 90%於二零二六年十二月三十一日前支付。雙方並 同意若青島公司於二零二六年盈利達 5,000 萬元人民幣，子公司將額外分享 青島公司盈利中的 10%，此款將於二零 ...

Core Insights - The Fourth China Nutritionist Development Conference was held in Zhuhai, focusing on industry dynamics and professional standards to enhance public health [1][3] Group 1: Fund Establishment and Purpose - Yihai Kerry Golden Dragon Fish announced a donation of 1.5 million yuan to establish the "China Nutrition Society - Fengyitang Nutritionist Navigation Fund" to address talent shortages in the nutrition sector [3][5] - The fund aims to support the training of nutritionists, particularly in impoverished areas, by providing financial assistance for exams and promoting community nutrition education [5][8] Group 2: Industry Challenges and Solutions - The nutrition industry faces challenges such as a lack of professional guidance and consumer misconceptions about health functional foods, which hinder the implementation of scientific dietary concepts [5][6] - The fund's initiatives are designed to cultivate a new generation of nutritionists who can bridge the gap between professional knowledge and public health needs [6][8] Group 3: Corporate Strategy and Product Development - Yihai Kerry Golden Dragon Fish is transitioning from traditional grain and oil production to a health-focused food strategy, responding to increasing consumer demand for nutritious products [9][12] - The company has developed a range of health-functional products, including low-GI rice and plant sterol protein milk, integrating traditional dietary wisdom with modern technology [12] Group 4: Recognition and Future Outlook - The company's products, such as Golden Dragon Fish Gu Weidu Rice Oil, received accolades at the conference, highlighting industry recognition of its health-oriented approach [11][12] - The establishment of the nutritionist fund is expected to enhance grassroots nutrition services and contribute to the realization of the "Healthy China" initiative [12]